A second “Biosimilar Week” is being rolled out in late May by Australia’s Generic and Biosimilar Medicines Association as part of education efforts underpinned by a three-year government grant.
“Biosimilar Awareness Week in 2020 will take place later this month from 25-29 May,” the GBMA announced, labelling the initiative “an opportunity for healthcare professionals and the Australian public to engage in a conversation about biosimilar medicines